FDA
-
-
-
-
-
-
-
Fibrocell to Present at BIO International Convention 2019
-
-
-
-
-
-
-
Fibrocell to Host Conference Call and Webcast on Wednesday, May 15, 2019 to Discuss First Quarter 2019 Financial Results and Recent Operational Highlights
-
-
-
-
-
-
-
Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007
-
-
-
-
-
-
-
Fibrocell Receives $900,000 Investment from EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation
-
-
-
-
-
-
-
Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007
-
-
-
-
-
-
-
Fibrocell Science (FCSC) Reports Q2 Loss of $1.03
-
-
-
-
-
-
-
Fibrocell Announces Oral Presentation at 7th International Investigative Dermatology Meeting
-
322,096 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

